AktiVax has been awarded a Department of Health and Human Services (DHHS) Biomedical Advanced Research and Development Agency (BARDA) contract to continue developing the ARAI auto-injector platform. Read the press release.
AktiVax's specialty pharma model uses investors’ capital to establish leadership in key markets.
If you would like to download a PDF of our preliminary investment information, please fill out the form.
Your privacy is important to us.